Sumitomo Life Insurance Co. Purchases 323 Shares of Clorox Company (The) (NYSE:CLX)

Sumitomo Life Insurance Co. increased its stake in Clorox Company (The) (NYSE:CLX) by 4.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,671 shares of the company’s stock after buying an additional 323 shares during the period. Sumitomo Life Insurance Co.’s holdings in Clorox Company (The) were worth $1,022,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of CLX. CrestPoint Capital Management LLC acquired a new stake in Clorox Company (The) during the first quarter valued at approximately $216,000. Spirit of America Management Corp NY acquired a new stake in Clorox Company (The) during the first quarter valued at approximately $243,000. Bank of Montreal Can raised its stake in Clorox Company (The) by 55.1% in the first quarter. Bank of Montreal Can now owns 369,031 shares of the company’s stock valued at $49,755,000 after buying an additional 131,122 shares in the last quarter. Pennsylvania Trust Co raised its stake in Clorox Company (The) by 3.8% in the first quarter. Pennsylvania Trust Co now owns 5,613 shares of the company’s stock valued at $757,000 after buying an additional 208 shares in the last quarter. Finally, National Pension Service raised its stake in Clorox Company (The) by 5.1% in the first quarter. National Pension Service now owns 105,642 shares of the company’s stock valued at $14,292,000 after buying an additional 5,107 shares in the last quarter. Institutional investors own 69.83% of the company’s stock.

Clorox Company (NYSE CLX) traded up 0.41% on Friday, hitting $137.73. 734,445 shares of the stock were exchanged. The company has a market cap of $17.78 billion, a PE ratio of 25.82 and a beta of 0.40. The company’s 50-day moving average is $133.55 and its 200-day moving average is $134.12. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same period last year, the company posted $1.30 EPS. The business’s quarterly revenue was up 2.9% compared to the same quarter last year. On average, analysts predict that Clorox Company will post $5.67 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This news story was reported by BNB Daily and is the property of of BNB Daily. If you are accessing this news story on another domain, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://www.baseball-news-blog.com/2017/08/19/sumitomo-life-insurance-co-boosts-position-in-clorox-company-the-nyseclx-updated.html.

CLX has been the topic of several recent research reports. Deutsche Bank AG reiterated a “hold” rating and issued a $137.00 price objective (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Vetr upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 price objective on the stock in a research report on Monday, April 24th. BMO Capital Markets reissued a “buy” rating and issued a $136.00 target price on shares of Clorox Company (The) in a research note on Thursday, May 4th. Zacks Investment Research downgraded shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Finally, BidaskClub downgraded shares of Clorox Company (The) from a “sell” rating to a “strong sell” rating in a research note on Monday, July 24th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. Clorox Company (The) currently has a consensus rating of “Hold” and a consensus price target of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply